Relentless Health Value

Real World Data (RWD) is not a synonym for Real World Evidence (RWE). Julie Locklear from Genesis Research explains why and what both mean. The importance of RWD and RWE is ballooning these days across all facets of the health care industry. Julie was on the podcast once before, Episode 144. We talked about value-based agreements and innovative contracting so this episode might be the prequel to that one. Value-based contract can’t exist without RWD/RWE. Definitely on the back end but it’d be pretty foolish to enter into a risk-based agreement of any kind without having data and evidence on the front end as well.

Julie is an executive pharmaceutical leader with over 20 years of experience across all phases of development both on the commercial and research sides of the organization. She leverages her Masters in Business Administration and Doctorate of Pharmacy to develop and deliver strategic patient-centric value propositions to optimize patient access and improve outcomes in patients with difficult to treat diseases leading to longer, healthier, and more productive lives. Her years of experience in global and US payer markets provides Julie with intimate knowledge of the current and evolving payer and market access landscape in the United States and around the globe. She has led the development and execution of several outcomes-based contracts with 3 of the largest national payer organizations in the US.
Julie is well published, having authored more than 30 publications in peer-reviewed journals and more than 60 peer-reviewed abstracts presented as posters at major scientific congresses.

00:00 Julie’s earlier episode – EP144 – the “prequel” to this episode.
01:45 Innovative contracting and outcomes based agreements.
02:00 RWD vs RWE.
03:15 The reason behind the RWD lag in health care.
03:35 Value-based pricing.
05:00 Who has the best information on a specific product according to who owns patient population RWD.
05:45 What RWE is, and how it differs from RWD.
06:15 How RWE stems from RWD.
07:20 Who hires these organizations and how they fit into the value chain.
09:10 Leveraging this data into workflows.
10:30 How pharma companies will utilize RWD.
13:35 Are pharma manufacturers being affected by RWE or RWD?
16:00 Is needing RWE becoming more prominent to US health care?
18:25 The different types of data and how that affects what sorts of conclusions various payers can come to.
21:30 The current gap for physicians at the point of care.
28:25 “Collaboration is a core skill.”
29:15 “You need to first ask around – you don’t know what you don’t know.”
30:25 “One of the most important things early on is just to listen.”
32:30 Genesis Research and their work.